Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2016 | Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner | Guo, JY; Hsu, HS; Tyan, SW; Li, FY; Shew, JY; Lee, WH; Chen, JY | Oncogene 36, 2457-2471 | | | |
2014 | Signal peptide peptidase-mediated nuclear localization of heme oxygenase-1 promotes cancer cell proliferation and invasion independent of its enzymatic activity. | Hsu, FF; Yeh, CT; Sun, YJ; Chiang, MT; Lan, WM; Li, FA; Lee, WH; Chau, LY | ONCOGENE 10.1038/onc.2014.166. [Epub ahead of print] | | | |
2015 | Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma. | Lin, CS; Adebayo, BO; Wu, A; Chen, JH; Peng, YJ; Cheng, MF; Lee, WH; Hsiao, M; Chao, TY; Yeh, CT | Cancer Letters 368(1), 36-45 | | | |
1988 | Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. | Huang, HJ; Yee, JK; Shew, JY; Chen, PL; Bookstein, R; Friedmann, T; Lee, EY; Lee, WH | Science 242(4885), 1563-1566 | | | |
1990 | Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. | Bookstein, R; Shew, JY; Chen, PL; Scully, P; Lee, WH | Science 247(4943), 712-715 | | | |
1988 | SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. | DeCaprio, JA; Ludlow, JW; Figge, J; Shew, JY; Huang, CM; Lee, WH; Marsilio, E; Paucha, E; Livingston, DM | Cell 54(2), 275-283 | | | |
2015 | Synthesis, molecular modeling, and biological evaluation of novel RAD51 inhibitors. | Zhu, J; Chen, H; Guo, XE; Qiu, XL; Hu, CM; Chamberlin, AR; Lee, WH | European journal of medicinal chemistry 96, 196-208 | | | |
2015 | Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines | Wu, HH; Hwang-Verslues, WW; Lee, WH; Huang, CK; Wei, PC; Chen, CL; Shew, JY; Lee, EY; Jeng, YM; Tien, YW; Ma, C; Lee, WH | Journal of Experimental Medicine 212(3), 333-349 | | | |
2015 | Targeting interleukin-17 receptors. | Lee, WH; Wu, HH; Huang, CK | Oncotarget 6(21), 18244-5 | | | |
2018 | The disruption of the β-Catenin/TCF-1/STAT3 signaling axis by 4-Acetylantroquinonol B inhibits the tumorigenesis and cancer stem-cell-like properties of glioblastoma cells, in vitro and in vivo | Liu, HW; Su, YK; Bamodu, OA; Hueng, DY; Lee, WH; Huang, CC; Deng, L; Hsiao, M; Chien, MH; Yeh, CT; Lin, CM | Cancers 10(12), 491 | | | |
2014 | The impact of chronic kidney disease on lipid management and goal attainment in patients with atherosclerosis diseases in Taiwan. | Lin, TH; Chuang, SY; Chu, CY; Lee, WH; Hsu, PC; Su, HM; Li, YH; Fang, CC; Wang, KY; Tseng, WK; Li, AH; Ueng, KC; Hsieh, IC; Huang, LC; Wang, CH; Pan, WH; Yeh, HI; Wu, CC; Yin, WH; Chen, JW | International journal of medical sciences 11(4), 381-388 | | | |
1987 | The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. | Lee, WH; Shew, JY; Hong, FD; Sery, TW; Donoso, LA; Young, LJ; Bookstein, R; Lee, EY | Nature 329(6140), 642-645 | | | |